01877nam a2200337Ia 4500001001200000003000800012005001700020006001900037007001500056008004100071015001500112020002100127040002100148035002100169050002600190082002300216110013000239245049400369260007400863300001400937504005100951533015201002650007101154650004401225650003201269650003701301655002901338700002401367710001701391856013101408ebr10056826CaPaEBR20260707174522.0m        u        cr cn|||||||||010215s1983    enk     sb    001 0 eng d  aGBA1-12110  z0309033969(pbk.)  aCaPaEBRcCaPaEBR  a(OCoLC)60769187214aHD9666.5b.N38 1983eb04a338.47615109732212 aNational Academy of Engineering.bCommittee on Technology and International Economic and Trade Issues.bPharmaceutical Panel.14aThe competitive status of the U.S. pharmaceutical industryh[electronic resource] :bthe influences of technology in determining international industrial competitive advantage /cprepared by the Pharmaceutical Panel Committee on Technology and International Economic and Trade Issues, Office of the Foreign Secretary National Academy of Engineering, Commission on Engineering and Technical Systems National Research Council  ; Charles C. Edwards, chairman  ; Lacy Glenn Thomas, rapporteur.  aWashington, D.C. ;a[Great Britain] :bNational Academy Press,c1983.  ax, 102 p.  aIncludes bibliographical references and index.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2009.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aPharmaceutical industryxTechnological innovationszUnited States. 0aPharmaceutical industryzUnited States. 0aCompetitionzUnited States. 0aDrugszUnited StatesxMarketing. 7aElectronic books.2local1 aEdwards, Charles C.2 aebrary, Inc.40uhttp://site.ebrary.com/lib/strathmore/Doc?id=10056826zAn electronic book accessible through the World Wide Web; click to view